PharmaFrontiers, developer of Tovaxin, has changed its name to Opexa.
http://c.moreover.com/click/here.pl?j560790198&w=464753
Change of name
Hmmm, they also did a 10 - 1 reverse stock split which took their price per share to $9.00. Lots of new company officers as well. This makes me think that they really have faith in the Tovaxin trials and are positioning themselves to move to the NASDAQ. I really hope this one turns out as well as the rumors have implied.
J
J
Yeay!!!! I love Tovaxin. Anything that even hints at the possibility that Tovaxin will do well makes my day. I think the vaccine totally makes sense. I just hope that only a few T cells need to be rid of and that new types of T cell that attack the myelin don't start developing other than the three they target. I also hope that there would not be an increase in cancer. Other than that I have no idea what else could go wrong using the vaccine. Last time I checked, there were plenty of things I did not know though. We'll have to wait and see. That'll be easy
NN
p.s. wasn't called Opexa before??????

NN
p.s. wasn't called Opexa before??????
- CureOrBust
- Family Elder
- Posts: 3374
- Joined: Wed Jul 27, 2005 2:00 pm
- Location: Sydney, Australia